Hong Kong Stock Movement | Innovent Biologics (01801.HK) Rises Over 3% as IBI3003 Clinical Data Validate Leading Position in MM TCE, Phase III Registrational Study Already Underway in China
Zhitong Finance APP has learned that Innovent Biologics (01801.HK) rose more than 3%, up 2.97% as of press time, at HK$90, with a turnover of HK$362 million.
Latest
